Middle East
Nucleix Expands EU Label Indication for Bladder Cancer Urine Test
The test measures DNA methylation patterns in urine that are associated with urothelial cancer and was first launched for monitoring tumor recurrence.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
Juniper Biologics to Sell Helsinn's Truseltiq in Certain Asia-Pacific, Africa, Middle East Markets
The deal gives Juniper exclusive rights to develop and commercialize Helsinn's bile duct cancer drug in 40 new countries.
Precision Cancer Diagnosis Firm Imagene AI Raises $21.5M
The Israeli startup is developing a technology that uses artificial intelligence to detect molecular cancer biomarkers from digital biopsy images.
Experts are working through challenges to make low-cost sequencing available at resource-limited hospitals around the world, starting with an institution in Pakistan.
Jan 5, 2022
Nucleix Raises Additional $22M
Mar 11, 2021
Jan 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
Jul 29, 2020